These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Preparation and evaluation of a timolol maleate drug-resin ophthalmic suspension as a sustained-release formulation in vitro and in vivo. Qin F, Zeng L, Zhu Y, Cao J, Wang X, Liu W. Drug Dev Ind Pharm; 2016 Jun 16; 42(4):535-45. PubMed ID: 26368660 [Abstract] [Full Text] [Related]
12. New mucoadhesive chitosan film for ophthalmic drug delivery of timolol maleate: in vivo evaluation. Fulgêncio Gde O, Viana FA, Ribeiro RR, Yoshida MI, Faraco AG, Cunha-Júnior Ada S. J Ocul Pharmacol Ther; 2012 Aug 16; 28(4):350-8. PubMed ID: 22320419 [Abstract] [Full Text] [Related]
13. Promoting effect of borneol on the permeability of puerarin eye drops and timolol maleate eye drops through the cornea in vitro. Wu CJ, Huang QW, Qi HY, Guo P, Hou SX. Pharmazie; 2006 Sep 16; 61(9):783-8. PubMed ID: 17020156 [Abstract] [Full Text] [Related]
14. The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case. Battistini FD, Tártara LI, Boiero C, Guzmán ML, Luciani-Giaccobbe LC, Palma SD, Allemandi DA, Manzo RH, Olivera ME. Eur J Pharm Sci; 2017 Jul 15; 105():188-194. PubMed ID: 28506871 [Abstract] [Full Text] [Related]
15. Physicochemical and pharmacological investigation of water/oil microemulsion of non-selective beta blocker for treatment of glaucoma. Hegde RR, Bhattacharya SS, Verma A, Ghosh A. Curr Eye Res; 2014 Feb 15; 39(2):155-63. PubMed ID: 24073659 [Abstract] [Full Text] [Related]
16. Exploring gelatin nanoparticles as novel nanocarriers for Timolol Maleate: Augmented in-vivo efficacy and safe histological profile. Shokry M, Hathout RM, Mansour S. Int J Pharm; 2018 Jul 10; 545(1-2):229-239. PubMed ID: 29709617 [Abstract] [Full Text] [Related]
18. Poly(N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery. Cao Y, Zhang C, Shen W, Cheng Z, Yu LL, Ping Q. J Control Release; 2007 Jul 31; 120(3):186-94. PubMed ID: 17582643 [Abstract] [Full Text] [Related]
19. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system. Gupta H, Jain S, Mathur R, Mishra P, Mishra AK, Velpandian T. Drug Deliv; 2007 Nov 31; 14(8):507-15. PubMed ID: 18027180 [Abstract] [Full Text] [Related]
20. Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models. Juretić M, Cetina-Čižmek B, Filipović-Grčić J, Hafner A, Lovrić J, Pepić I. Eur J Pharm Sci; 2018 Jul 30; 120():133-141. PubMed ID: 29702232 [Abstract] [Full Text] [Related] Page: [Next] [New Search]